Get started
Author

Prakash Kumar Sirvi

Lactoferrin-Anchored Carboxymethyl Pullulan-MgO Nanocomposites for Targeted Delivery of Trans-Ferulic Acid: Physicochemical Characterization, In vitro and Ex vivo Studies
2025 · Prakash Kumar Sirvi, Paul Gajanan Balaji, et al. · ACS Applied Bio Materials · 4
Reverse Engineering of Branded Mesalamine Prolonged Release Granules for Synthesis of QTPP and FMEA: A Systematic Approach for Oral Complex Generic Product Development
2026 · Sadhana Dhyagala, Ankit Kumar, et al. · AAPS PharmSciTech · 2
Patent Landscaping of Time-dependent Mesalamine Prolonged-release Granules: A Case Study for Generic Formulation Development
2025 · Ayush Rohila, Ankit Kumar, et al. · Journal of Pharmaceutical Innovation · 2
Understanding the Impact of Particle Size and Crystal Habit of Mesalamine Drug Substances on Their Packing, Wetting, and Dissolution Behaviour: A Science-based Approach for Selection of API Vendor
2026 · Prakash Kumar Sirvi, Ayush Rohila, et al. · AAPS PharmSciTech · 1
Understanding the Influence of Molarity, Buffer Capacity, and pH on Product-specific Guidance Dissolution Method for Developing a Discriminatory Dissolution Method for the Development of Mesalamine Products
2026 · Ankit Kumar, Sakshi Kunjir, et al. · AAPS PharmSciTech · 1
Therapeutic Hallmarks of Cancer and Immunology
2024 · Prakash Kumar Sirvi, Vishal Jadhav, et al. · Springer eBooks · 1
Dissolution behaviour of mesalamine nanocrystals, micronised crystals, suspensions, and tablets: a method development perspective
2026 · Sonam Sharma, Sakshi Anil Kunjir, et al. · Journal of Thermal Analysis and Calorimetry
Developing a process-discriminatory dissolution method as a critical quality attribute using ATR-FTIR coupled multivariate analysis as a PAT tool to ensure the coating robustness for mesalamine prolonged-release pellets
2026 · Sakshi Kunjir, Ankit Kumar, et al. · RSC Pharmaceutics
Novel targets and drugs for the treatment of tuberculosis
2025 · Farhan Mazahir, Prakash Kumar Sirvi, et al. · Elsevier eBooks
List of contributors
2025 · Tejas Girish Agnihotri, Abhijeet A. Aher, et al. · Elsevier eBooks
COVID-19 (SARS-COV-2) structural features, pathophysiology and current drug therapy
2023 · Amit Chirania, Dilkhush, et al. · World Journal of Biology Pharmacy and Health Sciences
PDF
Works count: 11
Citation count: 11
H-index: 2
I10-index:
Year
Topic
Type